Abstract
INTRODUCTION Cerebrospinal fluid (CSF) biomarkers of Alzheimer’s disease (AD) are reliable predictors of future AD risk. We investigated whether pre-clinical changes in AD CSF biomarkers are reflected in blood DNA methylation (DNAm) levels in cognitively normal participants.
METHODS We profiled blood-based DNAm with the EPIC array in participants without a diagnosis of cognitive impairment in the Emory Healthy Brain Study (EHBS; N=495) and ADNI (N=122). Their CSF Aβ42, tTau, and pTau levels were quantified using Elecsys immunoassays. We conducted epigenome-wide association studies to assess associations between DNAm and CSF biomarkers of AD.
RESULTS In EHBS, no loci were Bonferroni-significant after adjusting for confounding factors. In ADNI, two loci were significant, but they were not replicated in EHBS. There was little agreement between the top loci from EHBS and ADNI.
DISCUSSION Our study showed little evidence of an association between differential blood-based DNAm and pre-clinical AD CSF biomarkers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by I01 BX003853 (APW), I01 BX005686 (APW), IK4 BX005219 (APW), P30 AG066511 (AIL, JJL), R01 AG056533 (APW, TSW), R01 AG070937 (JJL), R01 AG072120 (APW, TSW), R01 AG075827 (APW, TSW), R01 AG079170 (AH, TSW), U01 AG046161 (AIL), U01 AG061356 (AIL), U01 AG061357 (AIL), U01 AG088425 (AH, TSW), R01AG087250 (AH)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Emory Healthy Brain Study was approved by the Institutional Review Board of Emory University Medical Center. All participants provided written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
